Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | +5.71% | +8.82% | -49.32% |
May. 08 | Top Premarket Gainers | MT |
May. 08 | Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue | MT |
Financials (USD)
Sales 2024 * | 59.87M | Sales 2025 * | 11.16M | Capitalization | 149M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -168M | EV / Sales 2024 * | -1.58 x |
Net cash position 2024 * | 243M | Net cash position 2025 * | 249M | EV / Sales 2025 * | -9.03 x |
P/E ratio 2024 * |
-1.55
x | P/E ratio 2025 * |
-1.07
x | Employees | 179 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.95% |
Latest transcript on Repare Therapeutics Inc.
1 day | +5.71% | ||
1 week | +8.82% | ||
Current month | +19.35% | ||
1 month | +6.63% | ||
3 months | -47.89% | ||
6 months | -1.07% | ||
Current year | -49.32% |
Managers | Title | Age | Since |
---|---|---|---|
Lloyd Segal
CEO | Chief Executive Officer | 60 | 16-05-31 |
Steve Forte
DFI | Director of Finance/CFO | 45 | 19-09-30 |
Michael Zinda
CTO | Chief Tech/Sci/R&D Officer | 53 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 19-02-28 |
Lloyd Segal
CEO | Chief Executive Officer | 60 | 16-05-31 |
Ann Rhoads
BRD | Director/Board Member | 58 | 20-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.33% | 0 M€ | 0.00% | - | |
0.15% | 115 M€ | +2.02% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 3.7 | +5.71% | 301 118 |
24-05-10 | 3.5 | -3.85% | 289,644 |
24-05-09 | 3.64 | -3.96% | 724,885 |
24-05-08 | 3.79 | +15.55% | 4,588,930 |
24-05-07 | 3.28 | -3.53% | 73,158 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.32% | 149M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- RPTX Stock